By Caroline Chen
May 18, 2016
The Bill & Melinda Gates Foundation received an unexpected boost to its coffers when a stake in a small biotechnology firm, made in 2013 to encourage the company’s work on neglected diseases, sold for $86.7 million — about 17 times the fund’s original investment.